Stem Cell Transplantation

1. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

Author
Jabbour E; Cortes J; Kantarjian HM; Giralt S; Jones D; Jones R; Giles F; Andersson BS; Champlin R; de Lima M;
Institution
Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Journal
Blood. 2006 Aug 15;108(4):1421-3. Epub 2006 Apr 6.
Abstract URL
Click here to view abstract

2. Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia.

Author
Heim D; Friess D; Christen S; Stussi G; Meyer-Monard S; Tichelli A; Passweg JR; Gratwohl A;
Institution
Journal
Leukemia. 2006 May;20(5):898-900.

3. Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.

Author
Giralt SA; Arora M; Goldman JM; Lee SJ; Maziarz RT; McCarthy PL; Sobocinski KA; Horowitz MM;
Institution
M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77230, USA. sgiralt@mdanderson.org
Journal
Br J Haematol. 2007 Jun;137(5):461-7. Epub 2007 Apr 24.
Abstract URL
Click here to view abstract

4. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

Author
Savani BN; Rezvani K; Mielke S; Montero A; Kurlander R; Carter CS; Leitman S; Read EJ; Childs R; Barrett AJ;
Institution
Stem Cell Allogeneic Transplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bldg 10, Hatfield CRC, Bethesda, MD 20892-1202, USA.
Journal
Blood. 2006 Feb 15;107(4):1688-95. Epub 2005 Aug 30.
Abstract URL
Click here to view abstract

5. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

Author
Baker KS; Loberiza FR Jr; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ;
Institution
Pediatric Blood and Marrow Transplant Program, University of Minnesota, Mayo Mail Code 484, Minneapolis, MN 55455, USA. baker084@umn.edu
Journal
J Clin Oncol. 2005 Oct 1;23(28):7032-42. Epub 2005 Sep 6.
Abstract URL
Click here to view abstract

6. Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

Author
Crawley C; Szydlo R; Lalancette M; Bacigalupo A; Lange A; Brune M; Juliusson G; Nagler A; Gratwohl A; Passweg J; Komarnicki M; Vitek A; Mayer J; Zander A; Sierra J; Rambaldi A; Ringden O; Niederwieser D; Apperley JF;
Institution
Clinical Haematology, Box 234, Addenbrookes Hospital, Cambridge, CB2 2QQ United Kingdom. charles.crawley@addenbrookes.nhs.uk
Journal
Blood. 2005 Nov 1;106(9):2969-76. Epub 2005 Jul 5.
Abstract URL
Click here to view abstract

7. A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors.

Author
Robin M; Guardiola P; Devergie A; Yeshurun M; Shapiro S; Esperou H; Ribaud P; Rocha V; Gluckman E; Socie G;
Institution
Service d'hematologie--greffe de moelle, Hopital Saint-Louis, APHP, Paris, Cedex, France.
Journal
Leukemia. 2005 Sep;19(9):1613-20.
Abstract URL
Click here to view abstract

8. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia.

Author
Carreras E; Jimenez M; Gomez-Garcia V; de la Camara R; Martin C; Martinez F; Iriondo A; Sanz G; Canizo C; Cabrera R; Sierra J; Vallejo C; Lopez J; Martinez C; Rovira M; Fernandez-Ranada JM; Torres A;
Institution
Spanish Bone Marrow Donor Registry (REDMO), IDIBAPS, Barcelona, Spain. carreras@clinic.ub.es
Journal
Bone Marrow Transplant. 2006 Jan;37(1):33-40.
Abstract URL
Click here to view abstract

9. Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment.

Author
Dazzi F; Fozza C;
Institution
Department of Haematology, Imperial College at Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Journal
Best Pract Res Clin Haematol. 2007 Jun;20(2):311-27.
Abstract URL
Click here to view abstract

10. Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation.

Author
Huang Q; Wu Y; Snyder DS; Chang KL; Slovak ML; Gaal KK; Palmer JM; Weiss LM;
Institution
Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Journal
Am J Clin Pathol. 2007 Oct;128(4):565-70.
Abstract URL
Click here to view abstract

11. Allogeneic hematopoietic stem cell transplantation in pediatric chronic myelogenous leukemia cases: Hacettepe experience.

Author
Unal S; Fidan G; Tavil B; Cetin M; Cetinkaya DU;
Institution
Division of Pediatric Hematology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Sihhiye, Ankara, Turkey. suleunal2003@hotmail.com
Journal
Pediatr Transplant. 2007 Sep;11(6):645-9.
Abstract URL
Click here to view abstract

12. Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.

Author
Jabbour E; Cortes J; Kantarjian H; Giralt S; Andersson BS; Giles F; Shpall E; Kebriaei P; Champlin R; de Lima M;
Institution
Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Journal
Cancer. 2007 Jul 15;110(2):340-4.
Abstract URL
Click here to view abstract

13. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.

Author
Liu FC; Chen CH; Chao TY;
Institution
Divisions of Rheumatology/Immunology/Allergy, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan, Republic of China.
Journal
Clin Rheumatol. 2007 Jul;26(7):1207-10. Epub 2006 Aug 26.
Abstract URL
Click here to view abstract

14. Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.

Author
Kebriaei P; Detry MA; Giralt S; Carrasco-Yalan A; Anagnostopoulos A; Couriel D; Khouri IF; Anderlini P; Hosing C; Alousi A; Champlin RE; de Lima M;
Institution
Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. pkebriaei@mdanderson.org
Journal
Blood. 2007 Nov 1;110(9):3456-62. Epub 2007 Jul 25.
Abstract URL
Click here to view abstract

15. Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy.

Author
Weisser M; Schleuning M; Haferlach C; Schwerdtfeger R; Kolb HJ;
Institution
Department of Medicine III, Klinikum Grosshadern, Ludwig Maximilians University of Munich, Germany. martin.weisser@gmx.de
Journal
Leuk Lymphoma. 2007 Feb;48(2):295-301.
Abstract URL
Click here to view abstract

16. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.

Author
Simon W; Segel GB; Lichtman MA;
Institution
Department of Biochemistry and Biophysics, University of Rochester School of Medicine, NY 14642, USA.
Journal
Blood Cells Mol Dis. 2006 Sep-Oct;37(2):116-24; discussion 125-7. Epub 2006 Aug 10.
Abstract URL
Click here to view abstract

17. Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia.

Author
Krejci M; Mayer J; Doubek M; Brychtova Y; Pospisil Z; Racil Z; Dvorakova D; Lengerova M; Horky O; Koristek Z; Dolezal T; Vorlicek J;
Institution
Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno, Czech Republic.
Journal
Bone Marrow Transplant. 2006 Oct;38(7):483-91. Epub 2006 Aug 28.
Abstract URL
Click here to view abstract

18. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.

Author
Baron, Frederic; Maris, Michael B; Storer, Barry E; Sandmaier, Brenda M; Stuart, Monic J; McSweeney, Peter A; Radich, Jerald P; Pulsipher, Michael A; Agura, Edward D; Chauncey, Thomas R; Maloney, David G; Shizuru, Judith A; Storb, Rainer;
Institution
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
Journal
Biol Blood Marrow Transplant 2005 Apr;11(4):272-9.
Abstract URL
Click here to view abstract

19. Relatively favorable outcomes of post-transplant pulmonary function in patients with chronic myeloid leukemia receiving non-myeloablative allogeneic hematopoietic stem cell transplantation.

Author
Lee, M Y; Chiou, T J; Yang, M H; Bai, L Y; Hsiao, L T; Chao, T C; Tung, S L; Wang, W S; Yen, C C; Liu, J H; Chen, P M;
Institution
Division of Medical Oncology, Department of Medicine, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan.
Journal
Eur J Haematol 2005 Feb;74(2):152-7.
Abstract URL
Click here to view abstract

20. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.

Author
Valcarcel, D; Martino, R; Sureda, A; Canals, C; Altes, A; Briones, J; Sanz, M A; Parody, R; Constans, M; Villela, S L; Brunet, S; Sierra, J;
Institution
Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.
Journal
Eur J Haematol 2005 Feb;74(2):144-51.
Abstract URL
Click here to view abstract

21. Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.

Author
Girgis, Mark; Hallemeier, Chris; Blum, William; Brown, Randy; Lin, Hsiu-San; Khoury, Hanna; Goodnough, L Tim; Vij, Ravi; Devine, Steve; Wehde, Marita; Postma, Stacey; Oza, Aarti; Dipersio, John; Adkins, Douglas;
Institution
Department of Internal Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis, MO 63110-1093, USA.
Journal
Blood 2005 Apr 15;105(8):3035-41. Epub 2004 May 4.
Abstract URL
Click here to view abstract